Ajay Shah, PhD
Co-Founder and CEO
Ajay is an expert in cell-based diagnostic technologies, as well as an experienced entrepreneur, having previously co-founded two life science companies (one acquired in 2012). Ajay received his PhD from the Harvard-MIT Division of Health Sciences and Technology, where he developed a novel platform for circulating tumor cell isolation under the supervision of Mehmet Toner and Daniel Haber at Massachusetts General Hospital.
Chief Operating Officer
Jennifer serves as Chief Operating Officer at Cytovale and oversees business operations. Bringing over 20 years of operational, general management and consulting experience, Jennifer’s roles have spanned domestic and global leadership in manufacturing, marketing, corporate strategy and business development. As co-founder of MedTechWomen, she helped launch the first conference for women leaders focused on major healthcare trends impacting the medical technology sector. Jennifer holds an MBA from Harvard Business School and a BS in chemical engineering from the University of Michigan.
Henry Tse, PhD
Co-Founder and CTO
Henry is Co-Founder and Chief Technology Officer for Cytovale, leading the research and development efforts to commercialize the microfluidic deformability cytometry technology. Henry's broad engineering and science background is rooted in his graduate work with Professor Dino Di Carlo. His science and engineering expertise spans microfluidics, cancer biology, image processing, and application proof-of-concept clinical studies. Henry is the co-inventor of the deformability cytometry platform, which has resulted in peer-reviewed publications of seminal papers of the technology, followed on by application specific papers, as well an accompanying suite of issued patents.